293 related articles for article (PubMed ID: 15319699)
1. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A
Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.
Morgante L; Epifanio A; Spina E; Di Rosa AE; Zappia M; Basile G; La Spina P; Quattrone A
Neurol Sci; 2002 Sep; 23 Suppl 2():S89-90. PubMed ID: 12548358
[TBL] [Abstract][Full Text] [Related]
3. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
Merims D; Balas M; Peretz C; Shabtai H; Giladi N
Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
[TBL] [Abstract][Full Text] [Related]
4. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
Giménez-Roldán S; Navarro E; Mateo D
Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
[TBL] [Abstract][Full Text] [Related]
5. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
Menza MM; Palermo B; Mark M
Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
[TBL] [Abstract][Full Text] [Related]
8. Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.
Katzenschlager R; Manson AJ; Evans A; Watt H; Lees AJ
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):295-7. PubMed ID: 14742609
[TBL] [Abstract][Full Text] [Related]
9. The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview.
Prohorov T; Klein C; Miniovitz A; Dobronevsky E; Rabey JM
J Neurol; 2006 Feb; 253(2):171-5. PubMed ID: 16096815
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R; Cummings J; Raman R; Thal L;
Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of quetiapine in Parkinson's patients with psychosis.
Targum SD; Abbott JL
J Clin Psychopharmacol; 2000 Feb; 20(1):54-60. PubMed ID: 10653209
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
Parsa MA; Bastani B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
Fernandez HH; Trieschmann ME; Burke MA; Jacques C; Friedman JH
Mov Disord; 2003 May; 18(5):510-4. PubMed ID: 12722164
[TBL] [Abstract][Full Text] [Related]
16. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
[TBL] [Abstract][Full Text] [Related]
17. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
Friedman JH
J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
